amotosalen has been researched along with Congenital Zika Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beau, F; Broult, J; Laperche, S; Lastère, S; Mallet, HP; Mauguin, S | 1 |
| Aubry, M; Lanteri, MC; Laughhunn, A; Musso, D; Santa Maria, F; Stassinopoulos, A | 1 |
2 other study(ies) available for amotosalen and Congenital Zika Syndrome
| Article | Year |
|---|---|
Impact on blood safety of the last arboviruses outbreaks in French Polynesia (2012-2018).
Topics: Arboviruses; Blood Donors; Blood Safety; Blood-Borne Pathogens; Chikungunya Fever; Dengue; Disease Outbreaks; Donor Selection; Furocoumarins; Humans; Photosensitizing Agents; Polynesia; RNA, Viral; Seroepidemiologic Studies; Viremia; Zika Virus Infection | 2020 |
Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination.
Topics: Animals; Blood Platelets; Chlorocebus aethiops; Furocoumarins; Humans; Platelet Transfusion; RNA, Viral; Ultraviolet Rays; Vero Cells; Viral Load; Virus Inactivation; Zika Virus; Zika Virus Infection | 2017 |